home / stock / rafa / rafa quote
Last: | $0.1105 |
---|---|
Change Percent: | -8.33% |
Open: | $0.1105 |
Close: | $0.1105 |
High: | $0.1105 |
Low: | $0.1105 |
Volume: | 500 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.1105 | $0.1105 | $0.1105 | $0.1105 | $0.1105 | 500 | 04-26-2024 |
$0.102 | $0.1015 | $0.102 | $0.102 | $0.1 | 21,144 | 04-25-2024 |
$0.1011 | $0.1249 | $0.1011 | $0.1249 | $0.1011 | 33,344 | 04-24-2024 |
$0.102 | $0.102 | $0.102 | $0.102 | $0.102 | 25,000 | 04-23-2024 |
$0.108 | $0.1099 | $0.108 | $0.1099 | $0.102 | 41,557 | 04-22-2024 |
$0.1025 | $0.102 | $0.1025 | $0.11 | $0.102 | 96,859 | 04-19-2024 |
$0.11 | $0.105 | $0.11 | $0.11 | $0.105 | 14,500 | 04-18-2024 |
$0.101 | $0.101 | $0.101 | $0.101 | $0.101 | 250 | 04-17-2024 |
$0.123 | $0.1229 | $0.123 | $0.123 | $0.1229 | 25,200 | 04-16-2024 |
$0.12 | $0.1237 | $0.12 | $0.1237 | $0.12 | 56,000 | 04-15-2024 |
$0.12 | $0.134 | $0.12 | $0.148 | $0.12 | 39,189 | 04-12-2024 |
$0.12 | $0.118565 | $0.12 | $0.13 | $0.11545 | 26,000 | 04-11-2024 |
$0.1182 | $0.1182 | $0.1182 | $0.1182 | $0.1182 | 1,750 | 04-10-2024 |
$0.129 | $0.11 | $0.129 | $0.129 | $0.11 | 52,450 | 04-09-2024 |
$0.12615 | $0.14 | $0.12615 | $0.14 | $0.11 | 58,666 | 04-08-2024 |
$0.13 | $0.137 | $0.13 | $0.1425 | $0.101 | 93,100 | 04-05-2024 |
$0.14805 | $0.14 | $0.14805 | $0.14805 | $0.14 | 44,170 | 04-03-2024 |
$0.14 | $0.1425 | $0.14 | $0.145 | $0.14 | 27,100 | 04-02-2024 |
$0.14 | $0.137 | $0.14 | $0.14 | $0.137 | 11,000 | 04-01-2024 |
$0.1475 | $0.154 | $0.1475 | $0.154 | $0.145 | 62,000 | 03-29-2024 |
News, Short Squeeze, Breakout and More Instantly...
Rafarma Pharma Company Name:
RAFA Stock Symbol:
OTCMKTS Market:
Wyoming, USA, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals (OTC: RAFA) - We are pleased to announce that Rapharma and its CEO Raivo Unt have entered into a preliminary agreement with Kelun Lifesciences (Pvt) Ltd, a pharmaceutical company based in Sri Lanka, on 17 November 2023. It ...
Russia, Moscow, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals (OTC: RAFA). The Company is pleased to announce that it has completed the restructuring, accounting and balance sheet procedures required to comply with GAAP auditing standards. Due to the changed geopolitical situa...
Nicosia, Cyprus, April 29, 2022 (GLOBE NEWSWIRE) -- Representatives of Rafarma Pharmaceuticals, Inc. (OTC: RAFA) visited Uzbekistan and discussed the prospects for the company's development in the territory of the innovative research and production pharmaceutical cluster "Tashkent Pharma Pa...